Evidence map›Paper›PMID 30641053›Full record

ArticleGastroenterology2019

Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes.

Saireudee Chaturantabut, Arkadi Shwartz, Kimberley J Evason, Andrew G Cox, Kyle Labella, Arnout G Schepers, Song Yang, Mariana Acuña, Yariv Houvras, Liliana Mancio-Silva and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Gastroenterology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Sexual dimorphism in the liver.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  4. Article
  5. EREG-secreting THBS1Hepatobiliary surgery and nutrition · 2026
    Article
  6. Observational
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Saireudee ChaturantabutGenetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Arkadi ShwartzGenetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Kimberley J EvasonDepartment of Pathology, University of Utah, Salt Lake City, Utah.
Andrew G CoxGenetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Kyle LabellaGenetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Arnout G SchepersKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Song YangStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.
Mariana AcuñaDivision of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, New York.
Yariv HouvrasDepartments of Surgery and Medicine, Weill Cornell Medical College, New York, New York.
Liliana Mancio-SilvaKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Shannon RomanoDepartment of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama.
Daniel A GorelickDepartment of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama.
David E CohenDivision of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, New York.
Leonard I ZonStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts; Howard Hughes Medical Institute, Chevy Chase, Maryland; Harvard Stem Cell Institute, Cambridge, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts.
Sangeeta N BhatiaKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts; Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Trista E NorthStem Cell Program, Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts; Harvard Stem Cell Institute, Cambridge, Massachusetts.
Wolfram GoesslingGenetics Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Harvard Stem Cell Institute, Cambridge, Massachusetts; Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Divison of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: wolfram_goessling@hms.harvard.edu.
Brigham and Women's Hospital · USBoston Children's Hospital · USCornell University · USBroad Institute · USMassachusetts Institute of Technology · USUniversity of Alabama at Birmingham · USUniversity of Utah · US

Funding

STRUCTURE-FUNCTION RELATIONSHIPS IN THE ALIMENTARY TRACTP30DK034854 · NIDDK · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JONATHAN C KAGAN · 1986 to 2026
$32.4M
Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLDR01DK056626 · NIDDK · YESHIVA UNIVERSITY · PI COHEN, DAVID E. · 2000 to 2024
$10.3M
Them1-Mediated Metabolic Regulation and Pathogenic Role in NAFLDR01DK103046 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI DAVID E. COHEN, Susan J Hagen · 2015 to 2026
$7.6M
Cancer Biology in the ZebrafishR01CA103846 · NCI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 2003 to 2022
$7.5M
A Community Zebrafish Resource for Modeling GWAS BiologyR24OD017870 · OD · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM, MACRAE, CALUM A. · 2014 to 2021
$6.3M
Regulation of Hepatic Lipid and Glucose Metabolism by PC-TP/StarD2R37DK048873 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI COHEN, DAVID E. · 2012 to 2021
$5.5M
Estrogen Regulation of Hepatic GrowthR01DK090311 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2011 to 2020
$4.9M
Metabolic Regulation of Liver GrowthR01DK105198 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOESSLING, WOLFRAM · 2016 to 2020
$2.7M
Metabolic regulation of hematopoietic stem cell specification and functionR01DK098241 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI NORTH, TRISTA E. · 2014 to 2018
$2.0M
Mechanisms and modifiers of beta-catenin-induced hepatic tumorigenesisK08CA172288 · NCI · UNIVERSITY OF UTAH · PI EVASON, KIMBERLEY JANE · 2013 to 2017
$754k
Howard Hughes Medical InstituteNCI NIH HHS K08 CA172288NCI NIH HHS R01 CA103846NIDDK NIH HHS P30 DK034854NIDDK NIH HHS R01 DK056626NIDDK NIH HHS R01 DK090311NIDDK NIH HHS R01 DK098241NIDDK NIH HHS R01 DK103046NIDDK NIH HHS R01 DK105198NIDDK NIH HHS R37 DK048873NIH HHS R24 OD017870
6 · The paper itself

Abstract

BACKGROUND &

aimsPatients with cirrhosis are at high risk for hepatocellular carcinoma (HCC) and often have increased serum levels of estrogen. It is not clear how estrogen promotes hepatic growth. We investigated the effects of estrogen on hepatocyte proliferation during zebrafish development, liver regeneration, and carcinogenesis. We also studied human hepatocytes and liver tissues.

methodsZebrafish were exposed to selective modifiers of estrogen signaling at larval and adult stages. Liver growth was assessed by gene expression, fluorescent imaging, and histologic analyses. We monitored liver regeneration after hepatocyte ablation and HCC development after administration of chemical carcinogens (dimethylbenzanthrazene). Proliferation of human hepatocytes was measured in a coculture system. We measured levels of G-protein-coupled estrogen receptor (GPER1) in HCC and nontumor liver tissues from 68 patients by immunohistochemistry.

resultsExposure to 17β-estradiol (E2) increased proliferation of hepatocytes and liver volume and mass in larval and adult zebrafish. Chemical genetic and epistasis experiments showed that GPER1 mediates the effects of E2 via the phosphoinositide 3-kinase-protein kinase B-mechanistic target of rapamycin pathway: gper1-knockout and mtor-knockout zebrafish did not increase liver growth in response to E2. HCC samples from patients had increased levels of GPER1 compared with nontumor tissue samples; estrogen promoted proliferation of human primary hepatocytes. Estrogen accelerated hepatocarcinogenesis specifically in male zebrafish. Chemical inhibition or genetic loss of GPER1 significantly reduced tumor development in the zebrafish.

conclusionsIn an analysis of zebrafish and human liver cells and tissues, we found GPER1 to be a hepatic estrogen sensor that regulates liver growth during development, regeneration, and tumorigenesis. Inhibitors of GPER1 might be developed for liver cancer prevention or treatment. TRANSCRIPT PROFILING: The accession number in the Gene Expression Omnibus is GSE92544.

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinogenesisCarcinoma, HepatocellularCell ProliferationEstradiolEstrogensFemaleGene ExpressionHepatocytesHumansLiverLiver CirrhosisLiver NeoplasmsLiver RegenerationMale9,10-Dimethyl-1,2-benzanthraceneEstradiolEstrogensGPER1 protein, humangper1 protein, zebrafishMTOR protein, humanmTOR protein, zebrafishPhosphatidylinositol 3-KinaseReceptors, EstrogenReceptors, G-Protein-CoupledTOR Serine-Threonine KinasesZebrafish ProteinsHepatocarcinogenesisSex HormoneSignal TransductionTranscription Regulation

Identifiers

PMID30641053
PMCPMC6532055
OpenAlexW2909828641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.